[HTML][HTML] Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancer
AB Schrock, C Ouyang, J Sandhu, E Sokol, D Jin… - Annals of …, 2019 - Elsevier
… Assessment of tumor mutational burden may be useful to … more somatic mutations and higher
neoantigen burden than non-… Tumor mutational burden (TMB) is an emerging biomarker for …
neoantigen burden than non-… Tumor mutational burden (TMB) is an emerging biomarker for …
Tumor mutational burden predicting the efficacy of immune checkpoint inhibitors in colorectal cancer: a systematic review and meta-analysis
Y Li, Y Ma, Z Wu, F Zeng, B Song, Y Zhang… - Frontiers in …, 2021 - frontiersin.org
… terms: (mutational burden OR mutation burden OR mutational load OR mutation load OR
TMB… ) AND (colon cancer OR colorectal cancer OR colorectal carcinoma OR colon carcinoma). …
TMB… ) AND (colon cancer OR colorectal cancer OR colorectal carcinoma OR colon carcinoma). …
[HTML][HTML] Correlation of tumor mutational burden and treatment outcomes in patients with colorectal cancer
SG Pai, BA Carneiro, YK Chae, RL Costa… - Journal of …, 2017 - ncbi.nlm.nih.gov
… The Cancer Genome Atlas (TCGA) showed that 16% of colorectal cancers (CRCs)
display DNA repair mechanisms and high tumor mutational burden (TMB). Although, there is …
display DNA repair mechanisms and high tumor mutational burden (TMB). Although, there is …
[HTML][HTML] Beyond microsatellite testing: assessment of tumor mutational burden identifies subsets of colorectal cancer who may respond to immune checkpoint …
DA Fabrizio, TJ George Jr, RF Dunne… - Journal of …, 2018 - ncbi.nlm.nih.gov
… across MSI-H colorectal cancers, but more importantly suggests that nearly 1 in every 33
MSS colorectal patients have an elevated mutational burden according to a classification based …
MSS colorectal patients have an elevated mutational burden according to a classification based …
Tumor mutation burden and prognosis in patients with colorectal cancer treated with adjuvant fluoropyrimidine and oxaliplatin
DW Lee, SW Han, JM Bae, H Jang, H Han, H Kim… - Clinical Cancer …, 2019 - AACR
… We analyzed tumor mutation burden (TMB) from targeted next-generation sequencing data
… with colorectal cancer. TMB was defined as total number of nonsynonymous mutations per …
… with colorectal cancer. TMB was defined as total number of nonsynonymous mutations per …
Mutational analysis of patients with colorectal cancer in CALGB/SWOG 80405 identifies new roles of microsatellite instability and tumor mutational burden for patient …
F Innocenti, FS Ou, X Qu, TJ Zemla… - Journal of Clinical …, 2019 - ascopubs.org
… In patients with metastatic colorectal cancer treated in first line, low TMB, and BRAF and
RAS mutations are negative prognostic factors. Patients with MSI-H tumors benefited more from …
RAS mutations are negative prognostic factors. Patients with MSI-H tumors benefited more from …
[HTML][HTML] Tumor Mutational Burden in Colorectal Cancer: Implications for Treatment
A Marques, P Cavaco, C Torre, B Sepodes… - Critical Reviews in …, 2024 - Elsevier
… of several advanced solid cancers, in colorectal cancer, the … Tumor mutational burden (TMB)
has emerged as a potential … Here, we compiled 45 colorectal cancer studies utilizing …
has emerged as a potential … Here, we compiled 45 colorectal cancer studies utilizing …
Histopathological characteristics and artificial intelligence for predicting tumor mutational burden-high colorectal cancer
Background Tumor mutational burden-high (TMB-H), which is detected with gene panel
testing, is a promising biomarker for immune checkpoint inhibitors (ICIs) in colorectal cancer (…
testing, is a promising biomarker for immune checkpoint inhibitors (ICIs) in colorectal cancer (…
Cytolytic activity correlates with the mutational burden and deregulated expression of immune checkpoints in colorectal cancer
A Zaravinos, C Roufas, M Nagara… - … & Clinical Cancer …, 2019 - Springer
… We provide proof of concept that the high mutational burden and cancer neoepitope load
are the primary drivers of immune activity in CRC. In addition, our findings highlight the need to …
are the primary drivers of immune activity in CRC. In addition, our findings highlight the need to …
Tumor mutational burden as a potential biomarker for PD1/PD-L1 therapy in colorectal cancer.
TJ George, GM Frampton, J Sun, K Gowen, M Kennedy… - 2016 - ascopubs.org
… As such, mutational burden determination from whole exome sequencing and … immunogenic
mutational burden. Herein, we explore the ability to quantify tumor mutational burden (TMB) …
mutational burden. Herein, we explore the ability to quantify tumor mutational burden (TMB) …
相关搜索
- patients with colorectal cancer mutational analysis
- metastatic colorectal cancer mutational analysis
- tumor mutational burden
- metastatic colorectal cancer microsatellite instability
- metastatic colorectal cancer low dose ipilimumab
- routine histology images colorectal cancer
- checkpoint blockade immunotherapy colorectal cancer
- metastatic colorectal cancer systematic review
- metastatic colorectal cancer mismatch repair
- colorectal cancer patients with kras mutations
- mutational profiling colorectal cancers
- metastatic colorectal cancer immune checkpoint inhibitors
- molecular pathways colorectal cancer
- metastatic colorectal cancer tumour mutational burden
- microsatellite instability high colorectal cancer